Today's News |
Prime Minister of Canada Announces Establishment of Centre for Advanced Medical Isotope Research and Development at TRIUMF
Tuesday, November 6, 2018Company Profile | Follow Company
Vancouver, BC, November 6, 2018--(T-Net)--TRIUMF welcomed Justin Trudeau, Prime Minister of Canada, last week for a special visit and announcement about public investments into medical isotope research and innovation infrastructure.
During his visit to Canada's particle accelerator centre, the Prime Minister announced funding to construct the new Institute for Advanced Medical Isotopes (IAMI), a premier centre for the life sciences that will expand Canada's role in fast-moving advances in nuclear medicine that will improve health and save lives.
The Institute for Advanced Medical Isotopes (IAMI) will be a state-of-the-art facility for research into next-generation, life-saving medical isotopes and radiopharmaceuticals.
Located on TRIUMF's campus, it will comprise an integrated series of labs and a TR-24 medical cyclotron, one of the most technologically advanced commercial cyclotrons in the world.
With investment from the Government of Canada, the Province of British Columbia, and contributions from TRIUMF, BC Cancer Foundation, the University of British Columbia, the construction of the IAMI facility is valued at $31.8M. With additional equipment and philanthropic funding, the total value of the IAMI project will be more than $50M.
IAMI will offer:
"The Institute for Advanced Medical Isotopes is a transformative project that will improve the health of Canadians. Through IAMI, TRIUMF and its partners will advance research into next-generation, life-saving medical isotopes and radiopharmaceuticals. IAMI will provide the facilities necessary to connect bench to bedside and translate scientific breakthroughs into real-world treatments for cancer and other diseases." said Dr. Jonathan Bagger, Director, TRIUMF.
"With the new IAMI facility and BC Cancer's partnership with TRIUMF we will have the most innovative infrastructure and minds working to develop advanced, highly targeted cancer therapeutics. Thanks to the vision and investments from the governments of Canada and British Columbia and a generous anonymous donation to BC Cancer Foundation, IAMI will bring hope and improve outcomes for people facing cancer across our nation." stated Dr. Francois Bénard, Vice President, Research, BC Cancer.
Related Links
About TRIUMF
TRIUMF is Canada's particle accelerator centre. From the hunt for the smallest particles in the universe to the development of new technologies, including next-generation batteries and medical isotopes, TRIUMF is pushing the frontiers in research to advance science, medicine, and business.
Company Snapshot |
||
Vancouver (Non-Tech Sectors)
|
Other Recent Company News |
|||||||||||||||||||
|